TAO Synergies Stock (NASDAQ:TAOX)

Financials Chart

Previous Close

$7.65

52W Range

$1.84 - $11.98

50D Avg

$7.17

200D Avg

$3.89

Market Cap

$16.32M

Avg Vol (3M)

$1.06M

Beta

2.03

Div Yield

-

TAOX Company Profile

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Jul 02, 2025

Website

TAOX Performance

TAOX Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	-	-	-
Net Income	$-12.77M	$-6.04M	$-5.57M
EBITDA	$-6.81M	$-8.31M	$-16.13M
Basic EPS	-	$-29.56	$-20.25
Diluted EPS	-	$-29.56	$-20.25

Fiscal year ends in Dec 24 | Currency in USD

TAO Synergies Stock (NASDAQ:TAOX)

TAOX Company Profile

TAOX Performance

TAOX Financial Summary

TAO Synergies Stock (NASDAQ:TAOX)